SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950134-08-009034
Filing Date
2008-05-09
Accepted
2008-05-09 09:00:39
Documents
8
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a40483e10vq.htm 10-Q 273613
2 EXHIBIT 10.19 a40483exv10w19.htm EX-10.19 3987
3 EXHIBIT 10.20 a40483exv10w20.htm EX-10.20 6657
4 EXHIBIT 10.21 a40483exv10w21.htm EX-10.21 2336
5 EXHIBIT 31.1 a40483exv31w1.htm EX-31.1 8548
6 EXHIBIT 31.2 a40483exv31w2.htm EX-31.2 8460
7 EXHIBIT 32.1 a40483exv32w1.htm EX-32.1 3499
8 EXHIBIT 32.2 a40483exv32w2.htm EX-32.2 3490
  Complete submission text file 0000950134-08-009034.txt   312125
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 08816139
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1